Recent Finacing
Recent Raise
Naurex is a clinical-stage biopharmaceutical company developing NMDA receptor subtype-selective modulators, including GLYX-13 and oral NRX-1074, to enhance synaptic plasticity for depression, TBI, and neuropathic pain.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
